Company / Current Liabilities per Share
Dyne Therapeutics, Inc. Current Liabilities per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.41
FY2024
5-year range
$0.41 / $0.83
FY2020-FY2024
Trend
-50.3%
vs FY2023
Sector context
#164 of 212
Health Care
What the data says
Dyne Therapeutics, Inc.'s current liabilities per share of $0.41 is lower than 77% of companies in the Health Care sector (FY2024). Improved from $0.50 to $0.41 over the past 2 years.
Based on SEC 10-K filings.
0.41 in FY2024 with a 5-year CAGR of -15.6%.
Improved from $0.50 to $0.41 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -9.9%
- 5-Year CAGR
- -15.6%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 212This company $0.41 Sector average $15.64
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 50.3% year-over-year.
- Ranks #164 out of 212 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.41 | -50.3% |
| FY2023 | $0.83 | +64.7% |
| FY2022 | $0.50 | -10.5% |
| FY2021 | $0.56 | -25.9% |
| FY2020 | $0.76 | -21.1% |
| FY2019 | $0.97 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026